Orphan drugs to grow twice as fast as rest of the industry: report
Despite the focus on high drug prices, orphan drugs are expected to grow at double the rate of the rest of the pharmaceutical industry over the next six years.
Kardashian's previous posts for Duchesnay's morning sickness treatments were slammed by the FDA for not including side effects or risk information.
Its campaign arms patients with questions to ask their doctors before they're prescribed an opioid.
The Beating Cancer Is in Our Blood brand positioning was developed with Oberland.